New gene therapy cures 1st New Yorker of sickle cell anemia

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...